MoneyWorks4Me

Samrat Pharmachem informs about compliance certificate

12 Oct 2022 Evaluate
Samrat Pharmachem has informed that it enclosed compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022, received from Link Intime India.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..